Non-Structural Protein-13 Mutations in European Isolates of SARS-CoV-2 Changed Protein Stability

Basit Öğe Kaydı
dc.contributor.authorALHAN, Mehmet Emin
dc.contributor.authorAKBULUT, EKREM
dc.date.accessioned2025-10-24T18:03:55Z
dc.date.available2025-10-24T18:03:55Z
dc.date.issued2024
dc.departmentMalatya Turgut Özal Üniversitesi
dc.description.abstractObjective: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) became one of the most important health problems of the 21st century. Non-structural protein-13 (nsp13/helicase) plays an important role in the replication of the viral genome and the viral life cycle. The SARS-CoV-2 genome has undergone thousands of mutations since the disease first appeared. Mutations pose a threat to the validity of therapeutics due to changes in protein structure. Modeling alterations caused by mutations in the viral proteome contributes to the development of effective antivirals. The changes in protein structure and stability caused by mutations seen in European isolates of SARS-CoV-2 were analyzed in the study with the aim of contributing to studies on the development of new anti-virals and the validity of existing therapeutics. Methods: The changes in protein structure after mutation were modeled with deep learning algorithms. The alterations in protein stability were analyzed by SDM2, mCSM, DUET and DynaMut2. Results: The mutation analysis revealed four (Pro77Leu, Gly170Ser, Tyr324Cys, and Arg392Cys) missense mutations in the nsp13 protein in European isolates of SARS-CoV-2. Mutations caused changes in protein structure (rmsd 0.294 Å) and stability (-.58 ? ??G ? .003 kcal.mol-1). The atomic interactions formed by the mutant residues in the three-dimensional conformation of the protein have changed. Conclusion: The mutations seen in European isolates for nsp13 of SARS-CoV-2 may lead to the emergence of different phenotypes in terms of viral activity. For this reason, the study may contribute to the success of the fight against the virus with different treatment approaches in different regions.
dc.identifier.doi10.33808/clinexphealthsci.1467615
dc.identifier.endpage1033
dc.identifier.issn2459-1459
dc.identifier.issue4
dc.identifier.startpage1028
dc.identifier.trdizinid1295277
dc.identifier.urihttps://doi.org/10.33808/clinexphealthsci.1467615
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1295277
dc.identifier.urihttps://hdl.handle.net/20.500.12899/2506
dc.identifier.volume14
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.relation.ispartofClinical and Experimental Health Sciences
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzTR-Dizin_20251023
dc.subjectCOVID-19
dc.subjectSARS-CoV-2
dc.subjectmutation
dc.subjecthelicase
dc.subjectnsp13
dc.titleNon-Structural Protein-13 Mutations in European Isolates of SARS-CoV-2 Changed Protein Stability
dc.typeArticle

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu